07 Jan 2001

Aspaime topico - España

Aspaime topico Description, Presentation and Dosage

Aspaime topico Description

Aspaime topico Drug Class Description

Otros preparados dermatologicos

Aspaime topico Drug Description

POMADA

Aspaime topico Manufacturer

ORT FARMA

Related Learning Zones

LAL-D Knowledge Centre

LAL-D Knowledge Centre

The Lysosomal Acid Lipase (LAL) Deficiency Knowledge Centre contains a range of accurate, informative clinical content for healthcare professionals. The disease awareness section presents epidemiology, pathophysiology and diagnosis information, among others. The treatment section details the drug characteristics, safety and efficacy of sebelipase alfa – the first and only licenced treatment for LAL deficiency. The resources section contains further clinical content including a video channel presenting expert opinions on diagnostic approach and current prognosis.

Developed by EPG Health Media (Europe) Ltd for epgonline.org, in collaboration and with content provided by Alexion Pharma GmbH

Obesity CME series

Obesity CME series

This European Obesity Initiative CME series contains three online modules, which are ideal for healthcare professionals looking to widen their understanding of obesity as a serious medical illness. Each module is EACCME-accredited and free to complete. Successful completion of the series will earn participants a combined total of 5 European CME credits (ECMECs).

Aspaime topico Dosage

Aspaime topico Precautions, Reactions and Contraindications

Aspaime topico Special Precautions

Related Drugs - Dermatología

Back to top